<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 64-year-old woman with <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo>, IgG lambda type Durie-Salmon Stage II, was admitted because of gradually developing <z:hpo ids='HP_0001903'>anemia</z:hpo> and increased blasts with abnormal karyotype in her bone marrow after 10 years of treatment </plain></SENT>
<SENT sid="1" pm="."><plain>The chromosomal analysis showed 44, XX, del(5q), del(7q), -9, add(12p), -21, typical of <z:e sem="disease" ids="C0280745" disease_type="Neoplastic Process" abbrv="">secondary MDS</z:e> due to the cumulative <z:chebi fb="0" ids="22333">alkylating agents</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0001894'>Thrombocytosis</z:hpo> concomitantly occurred with emergence of chromosomal abnormality, but the serum interleukin 6 level was not elevated, which suggested that it was related to development of <z:e sem="disease" ids="C0280745" disease_type="Neoplastic Process" abbrv="">secondary MDS</z:e> </plain></SENT>
</text></document>